...
首页> 外文期刊>Inflammation >Omega-3 polyunsaturated fatty acids delay the progression of endotoxic shock-induced myocardial dysfunction
【24h】

Omega-3 polyunsaturated fatty acids delay the progression of endotoxic shock-induced myocardial dysfunction

机译:Omega-3多不饱和脂肪酸延迟内毒素性休克诱发的心肌功能障碍的发展

获取原文
获取原文并翻译 | 示例
           

摘要

Septic shock has a high mortality rate, partially related to myocardial dysfunction. Polyunsaturated fatty acids (omega-3 PUFAs) possess anti-inflammatory and antioxidant properties, but whether omega-3 PUFAs exert beneficial effects on myocardial function is unknown. We investigated, in a rat model of endotoxic shock, the effects of omega-3 PUFAs pretreatment on cardiac hemodynamics, function, and oxidative stress as well as intestinal barrier. Endotoxic shock was induced by lipopolysaccharide (LPS; 20 mg/kg IP) administered to rats pretreated or not with omega-3 PUFAs (Omegaven?; 0.5 g/kg IP, 90 min before injection of LPS). Two or 5 h after LPS, left ventricular function and arterial pressure were measured, followed by assessment left ventricular total glutathione as well as tumor necrosis factor alpha expression, occuldin expression, and proteasome activities. LPS reduced mean arterial blood pressure to the same extent 2 and 5 h after its administration, but cardiac output was more markedly decreased after 5 h. Omega-3 PUFAs pretreatment did not significantly modify the effect of LPS on mean arterial pressure and total peripheral resistance, but prevented the decrease in cardiac output 2 h after LPS. LPS increased oxidized glutathione after 2 h, and this increase was significantly attenuated by omega-3 PUFAs. Simultaneously, omega-3 PUFAs increased myocardial hemeoxygenase-1 (HO-1) mRNA expression. Finally, omega-3 PUFAs prevented the reduction of intestinal occludin expression. Omega-3 PUFAs pre-treatment improves myocardial dysfunction during endotoxemia and increases myocardial HO-1 expression. Moreover, the preservation of the intestinal occludin induced by omega-3 PUFAs precedes myocardial protection, suggesting the involvement of the intestinal barrier in the myocardial improvement observed with omega-3 PUFAs parenteral supplementation.
机译:败血性休克死亡率高,部分与心肌功能障碍有关。多不饱和脂肪酸(omega-3 PUFA)具有抗炎和抗氧化的特性,但是尚不清楚omega-3 PUFA是否对心肌功能产生有益作用。我们在内毒素休克的大鼠模型中研究了omega-3 PUFA预处理对心脏血液动力学,功能和氧化应激以及肠屏障的影响。内毒素性休克是由脂多糖(LPS; 20 mg / kg IP)给予经或未经omega-3 PUFA(Omegaven ?; 0.5 g / kg IP,注射LPS前90分钟)预处理的大鼠给药的。 LPS后2或5小时,测量左心室功能和动脉压,然后评估左心室总谷胱甘肽以及肿瘤坏死因子α表达,occuldin表达和蛋白酶体活性。 LPS给药后2小时和5小时将平均动脉血压降低至相同程度,但5小时后心输出量明显下降。 Omega-3 PUFAs预处理并未显着改变LPS对平均动脉压和总外周阻力的作用,但可防止LPS后2 h心输出量下降。 LPS在2小时后增加了氧化型谷胱甘肽,而这种增加被omega-3 PUFA明显减弱了。同时,omega-3 PUFA增加了心肌血氧合酶-1(HO-1)mRNA的表达。最后,omega-3 PUFAs阻止了肠粘连蛋白表达的降低。 Omega-3 PUFA的预处理可改善内毒素血症期间的心肌功能障碍,并增加心肌HO-1的表达。此外,由omega-3 PUFA诱导的肠粘连蛋白的保存先于心肌保护,这表明肠屏障参与了omega-3 PUFAs肠胃外补充剂所观察到的心肌改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号